Daily as of 3 Nov 16:00 ET
- Price
- below both $8.57 vs 50 $8.58 / 200 $8.76
- Projection
- No cross projected
- Test
- Active cross test, 1 bar at the 50, 2 bars left
- Last cross
- 💀Death cross 27 Oct 2026 · projected 28 bars out
BCRX | BioCryst PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$8.57
+$0.33 (+3.94%)
BioCryst Pharmaceuticals (BCRX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
Right now the daily is the chart to watch. BCRX printed a death cross in Oct 2026, and price has already pulled back to the 50 inside the seven-bar window, so the cross test is open. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $8.47 vs 50 $8.48 / 200 $7.74
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 29 Jun 2026 · projected 7 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $8.57 vs 50 $8.13 / 200 $9.09
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 22 Sep 2026 · projected 16 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 27 Oct 2026 | 💀Death steep | daily | 28 bars out | Active Cross Test |
| 22 Sep 2026 | 💀Death | 4-hour | 16 bars out | Not tested |
| week of 29 Jun 2026 | 🟨Golden flat | weekly | 7 bars out | Not tested |
| week of 20 Apr 2026 | 💀Death flat | weekly | not projected | 5 bar cross test |
| week of 13 Apr 2026 | 🟨Golden flat | weekly | 29 bars out | Not tested |
About BCRX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$37.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid